ALN	Axillary Lymph Node metastasis
ARS	Artificial Reference Sequence
BLIA	Basal Like Immune Activated
BLIS	Basal Like Immune Suppressed
CAN	Copy Number Alterations
FFPE	Formalin-Fixed Paraffin-Embedded
HRD	Homologous Recombination Deficiency
IBC	Imflammatory Breast Cancer
ICPI	Immune Checkpoint Inhibitors
LAR	Luminal Androgen Receptor
MES	Mesenchymal-like
MGC	Maxam-Gilbert Chemical Cleavage
NAC	Neo Adjuvant Chemotherapy
NGS	Next-Generation Sequencing
NGSH	Next-Generation Sequencing by Hybridization
NGSS	Next-Generation Sequencing by Synthesis
NST	Ductal Carcinoma of Not Special Type
ONT	Oxford Nanopore Technology
pCR	Pathological Complete Response
SBS	Sanger Sequencing By Synthesis
SMRT	Single Molecule Real Time
ST	Ductal Carcinoma of Special Type
TMB	Tumor Mutation Burden
TNBC	Triple-Negative Breast Cancer
VUS	Variations of Unknown/Uncertain Significance
ZMW	Zero-Mode Waveguide